Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion (Q39174457)
Jump to navigation
Jump to search
scientific article published on 27 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion |
scientific article published on 27 March 2013 |
Statements
1 reference
Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion (English)
1 reference
Jing Wang
1 reference
Natalie W Pursell
1 reference
Maria Elena S Samson
1 reference
Ruzanna Atoyan
1 reference
Anna W Ma
1 reference
Abdelkader Selmi
1 reference
Wanlu Xu
1 reference
Xiong Cai
1 reference
Maurizio Voi
1 reference
Pierre Savagner
1 reference
Cheng-Jung Lai
1 reference
27 March 2013
1 reference
1 reference
12
1 reference
6
1 reference
925-936
1 reference
1 reference
Identifiers
1 reference
1 reference